Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Serby

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Psychiatric Quarterly|June 17, 1998
Training in community psychiatry: new opportunitiesN L Cohen, H McQuistion, G Albert, et al.
Annals of Neurology|October 1, 1979
Dementia in Parkinson DiseaseA Lieberman, M Dziatolowski, M Kupersmith, et al.
Biological Psychiatry|March 1, 1996
Olfactory identification deficits in relatives of Alzheimer's disease patientsM Serby, C Mohan, M Aryan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Clinical stages of dementia and the dexamethasone suppression testM Serby, D Zucker, M Kaufman, et al.
Biological Psychiatry|July 1, 1990
Scopolamine and olfactory functionM Serby, C Flicker, B Rypma, et al.
Journal of Clinical Psychopharmacology|February 1, 1983
Plasma cortisol values after dexamethasone in depressed inpatientsE D Peselow, M Serby, A Wolkin, et al.
Psychopharmacology Bulletin|January 1, 1984
Cholecystokinin octapeptide in dementiaM Serby, B Angrist, J Corwin, et al.
Lancet (London, England)|November 24, 1979
Pergolide and lisuride for Parkinson's diseaseA N Lieberman, M Leibowitz, A Neophytides, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1991
The effects of electroconvulsive shock on dopamine-1 and dopamine-2 receptor ligand binding activity in MPTP-treated miceH Sershen, T Wolinsky, R Douyon, et al.
Archives of Neurology|August 6, 2000
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditionsV Haroutunian, M Serby, D P Purohit, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Psychiatric Quarterly|June 17, 1998
Training in community psychiatry: new opportunitiesN L Cohen, H McQuistion, G Albert, et al.
Annals of Neurology|October 1, 1979
Dementia in Parkinson DiseaseA Lieberman, M Dziatolowski, M Kupersmith, et al.
Biological Psychiatry|March 1, 1996
Olfactory identification deficits in relatives of Alzheimer's disease patientsM Serby, C Mohan, M Aryan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Clinical stages of dementia and the dexamethasone suppression testM Serby, D Zucker, M Kaufman, et al.
Biological Psychiatry|July 1, 1990
Scopolamine and olfactory functionM Serby, C Flicker, B Rypma, et al.
Journal of Clinical Psychopharmacology|February 1, 1983
Plasma cortisol values after dexamethasone in depressed inpatientsE D Peselow, M Serby, A Wolkin, et al.
Psychopharmacology Bulletin|January 1, 1984
Cholecystokinin octapeptide in dementiaM Serby, B Angrist, J Corwin, et al.
Lancet (London, England)|November 24, 1979
Pergolide and lisuride for Parkinson's diseaseA N Lieberman, M Leibowitz, A Neophytides, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1991
The effects of electroconvulsive shock on dopamine-1 and dopamine-2 receptor ligand binding activity in MPTP-treated miceH Sershen, T Wolinsky, R Douyon, et al.
Archives of Neurology|August 6, 2000
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditionsV Haroutunian, M Serby, D P Purohit, et al.
Pageof 5